
WuXi Biologics (2269.HK) announced that it has been named by Morningstar Sustainalytics as both an Industry ESG Leader and a Regional ESG Leader for 2026, marking the sixth consecutive year the company has received the recognition. The award highlights WuXi Biologics’ commitment to advancing sustainability across its global business operations…



